ALHC
Alignment Healthcare, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-41/100
Last price
8.39
▼ 0.11 (1.28%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
8.49
Prev close
8.50
Day high
8.74
Day low
8.18
Volume
10.76M
Market cap
$1.74B
P/E (TTM)
44.05
52W range
7.37 – 25.12
Day trading desk
Gap from prior close
-0.12%
Prior close 8.50
VWAP
8.39
+0.07% from price
Relative volume
1.31×
Normal
Session range
19.35%
7.75 – 9.25
Position in range
43%
Mid range
ATR (14D)
0.56
6.67% of price
Prior day high
8.56
PDH
Prior day low
8.00
PDL
Bid / ask spread
—
Quote not published
Session volume
9.94M
Avg 7.59M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+5.82%
+3.9%
1M
-38.18%
-39.3%
3M
-58.21%
-62.7%
6M
-61.36%
-79.5%
YTD
-57.62%
-71.9%
1Y
-49.64%
-66.1%
3Y
+20.61%
-61.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ALHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-2.38M
Net selling
Buy transactions
6
486.66K shares
Sell transactions
20
2.87M shares
Net transactions
+26
Buys less sells
Sell : buy shares
5.9 : 1
Heavily one-sided
Insider-held shares
5.33M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 14, 26 | KAO JOHN Chief Executive Officer |
SELL | 27.40K | $356.20K | Indirect |
| Sep 11, 26 | KAO JOHN Chief Executive Officer |
SELL | 557.87K | $7.12M | |
| Sep 11, 26 | MARONEY DAWN CHRISTINE President |
SELL | 122.71K | $1.56M | Direct |
| Aug 14, 26 | MARONEY DAWN CHRISTINE President |
SELL | 5.00K | $70.00K | Direct |
| Aug 10, 26 | KAO JOHN Chief Executive Officer |
SELL | 298.00K | $4.14M | Indirect |
| Jul 15, 26 | MARONEY DAWN CHRISTINE President |
SELL | 177.07K | $3.69M | Direct |
| Jul 15, 26 | MARONEY DAWN CHRISTINE President |
CONVERSION | 152.07K | $1.38M | Direct |
| Jul 10, 26 | KAO JOHN Chief Executive Officer |
SELL | 298.00K | $5.92M | Indirect |
| Jul 1, 26 | KONOWIECKI JOSEPH S Officer and Director |
SELL | 25.00K | $600.00K | Direct |
| Jul 1, 26 | HOCHRADEL SHANE J Chief Operating Officer |
STOCK | 87.72K | $0 | Direct |
| Jun 26, 26 | KONOWIECKI JOSEPH S Officer and Director |
SELL | 25.00K | $575.00K | Direct |
| Jun 18, 26 | KONOWIECKI JOSEPH S Officer and Director |
SELL | 25.00K | $550.00K | Direct |
| Jun 15, 26 | MARONEY DAWN CHRISTINE President |
SELL | 30.00K | $586.42K | Direct |
| Jun 12, 26 | KIM HYONG J Officer |
SELL | 35.95K | $713.95K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FREEMAN ROBERT THOMAS |
Chief Financial Officer | 1.56M | Sale |
GENERAL ATLANTIC ALN HLTH, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
GENERAL ATLANTIC L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
KAO JOHN |
Chief Executive Officer | — | Sale |
KARDES HAKAN |
Chief Executive Officer | 678.99K | Sale |
KIM HYONG J |
Officer | 331.75K | Sale |
KONOWIECKI JOSEPH S |
Officer and Director | 1.10M | Sale |
MARONEY DAWN CHRISTINE |
President | 794.61K | Sale |
MCCLELLAN MARK B |
Director | 370.53K | Stock Award(Grant) |
SCAVO ROBERT L |
Chief Technology Officer | 487.69K | Sale |
Fundamentals
Market cap$1.74B
Enterprise value$1.37B
Revenue (TTM)$4.58B
Gross profit$574.42M
EBITDA$87.42M
Net income$40.70M
EPS (TTM)$0.19
Free cash flow$188.58M
Total cash$701.71M
Total debt$330.50M
Book value / share$1.28
Shares outstanding207.44M
Float188.51M
Short % of float12.20%
Dividend yield0.00%
Beta (5Y)1.14
Valuation & profitability ratios
Trailing P/E44.05
Forward P/E11.12
PEG ratio—
Price / sales—
Price / book6.54
EV / revenue0.30
EV / EBITDA15.62
Gross margin12.55%
Operating margin3.15%
Profit margin0.89%
Return on equity20.04%
Return on assets3.07%
Debt / equity124.66
Current ratio1.70
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.95B | $2.70B | $1.82B | $1.43B | +46.1% |
| Operating revenue | $3.91B | $2.67B | $1.80B | $1.43B | +46.4% |
| Cost of revenue | $3.46B | $2.41B | $1.62B | $1.25B | +43.8% |
| Gross profit | $488.56M | $296.69M | $201.03M | $184.28M | +64.7% |
| Selling, general & admin | $443.41M | $371.37M | $307.43M | $295.65M | +19.4% |
| Total operating expense | $473.81M | $398.25M | $328.85M | $312.92M | +19.0% |
| Operating income | $14.75M | -$101.56M | -$127.82M | -$128.64M | +114.5% |
| Net interest income | -$15.80M | -$23.55M | -$21.23M | -$18.29M | +32.9% |
| Pre-tax income | -$958.00K | -$128.05M | -$148.19M | -$149.30M | +99.3% |
| Tax provision | $20.00K | $21.00K | -$22.00K | $339.00K | -4.8% |
| Net income | -$724.00K | -$128.03M | -$148.02M | -$149.55M | +99.4% |
| Net income to common | -$724.00K | -$128.03M | -$148.02M | -$149.55M | +99.4% |
| Basic EPS | 0.00 | -0.67 | -0.79 | -0.83 | +100.0% |
| Diluted EPS | 0.00 | -0.67 | -0.79 | -0.83 | +100.0% |
| EBIT | $14.84M | -$104.50M | -$126.96M | -$131.01M | +114.2% |
| EBITDA | $45.32M | -$77.44M | -$105.30M | -$113.53M | +158.5% |
| Basic shares | 198.01M | 190.79M | 186.21M | 181.21M | +3.8% |
| Diluted shares | 198.01M | 190.79M | 186.21M | 181.21M | +3.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $575.82M | $432.86M | $202.90M | $409.55M | +33.0% |
| Cash & short-term investments | $604.23M | $470.65M | $318.82M | $409.55M | +28.4% |
| Accounts receivable | $253.21M | $153.90M | $119.75M | $92.89M | +64.5% |
| Total current assets | $951.58M | $661.64M | $483.54M | $544.55M | +43.8% |
| Property, plant & equipment | $71.27M | $74.96M | $61.86M | $42.99M | -4.9% |
| Goodwill & intangibles | $36.61M | $39.38M | $40.08M | $40.29M | -7.0% |
| Total assets | $1.07B | $782.06M | $591.88M | $633.86M | +36.3% |
| Total current liabilities | $556.87M | $351.85M | $263.02M | $229.96M | +58.3% |
| Long-term debt | $323.18M | $321.43M | $161.81M | $160.90M | +0.5% |
| Total debt | $329.64M | $329.26M | $170.79M | $164.60M | +0.1% |
| Total liabilities | $886.51M | $681.11M | $433.81M | $394.56M | +30.2% |
| Retained earnings | -$1.01B | -$1.01B | -$880.26M | -$732.24M | -0.1% |
| Shareholder equity | $179.28M | $99.85M | $156.95M | $238.13M | +79.5% |
| Working capital | $394.71M | $309.79M | $220.51M | $314.58M | +27.4% |
| Net tangible assets | $142.67M | $60.48M | $116.87M | $197.84M | +135.9% |
| Shares issued | 204.15M | 191.78M | 188.95M | 187.28M | +6.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$978.00K | -$128.07M | -$148.17M | -$149.64M | — | +99.2% |
| Depreciation & amortisation | $30.48M | $27.06M | $21.67M | $17.49M | — | +12.6% |
| Stock-based compensation | $62.08M | $71.13M | $66.83M | $81.72M | — | -12.7% |
| Change in working capital | $45.51M | $60.89M | $2.03M | -$5.55M | — | -25.3% |
| Operating cash flow | $139.93M | $34.77M | -$59.19M | -$45.43M | — | +302.4% |
| Capital expenditure | -$26.78M | -$41.42M | -$35.99M | -$23.77M | — | +35.3% |
| Investing cash flow | -$14.97M | $39.19M | -$147.26M | -$28.22M | — | -138.2% |
| Share buybacks | — | — | $0 | $0 | -$1.47M | — |
| Financing cash flow | $18.04M | $156.03M | $105.00K | $16.59M | — | -88.4% |
| Free cash flow | $113.15M | -$6.65M | -$95.18M | -$69.20M | — | +1,802.0% |
| End cash position | $577.94M | $434.94M | $204.95M | $411.30M | — | +32.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.34B | $1.24B | $1.01B | $993.70M | $1.02B | +8.1% |
| Operating revenue | $1.33B | $1.23B | $1.00B | $983.68M | $1.01B | +8.2% |
| Cost of revenue | $1.15B | $1.09B | $889.49M | $868.02M | $881.74M | +5.9% |
| Gross profit | $180.96M | $144.48M | $123.31M | $125.67M | $133.55M | +25.2% |
| Selling, general & admin | $131.00M | $121.14M | $125.76M | $110.02M | $103.80M | +8.1% |
| Total operating expense | $138.86M | $128.98M | $133.59M | $117.99M | $110.80M | +7.7% |
| Operating income | $42.10M | $15.50M | -$10.28M | $7.68M | $22.75M | +171.6% |
| Net interest income | -$4.28M | -$4.06M | -$3.95M | -$3.95M | -$3.95M | -5.2% |
| Pre-tax income | $37.83M | $11.44M | -$14.23M | $3.73M | $18.88M | +230.6% |
| Tax provision | $1.27M | $25.00K | -$3.23M | $2.00K | $3.22M | +4,964.0% |
| Net income | $36.56M | $11.42M | -$11.01M | $3.73M | $15.67M | +220.3% |
| Net income to common | $36.56M | $11.42M | -$11.01M | $3.73M | $15.67M | +220.3% |
| Basic EPS | 0.18 | 0.06 | -0.05 | 0.02 | 0.08 | +200.0% |
| Diluted EPS | 0.17 | 0.05 | -0.05 | 0.02 | 0.07 | +240.0% |
| EBIT | $42.10M | $15.50M | -$10.28M | $7.68M | $22.83M | +171.6% |
| EBITDA | $49.96M | $23.36M | -$2.45M | $15.67M | $29.86M | +113.8% |
| Basic shares | 207.45M | 205.36M | 200.97M | 199.03M | 198.33M | +1.0% |
| Diluted shares | 215.02M | 213.13M | 200.97M | 208.93M | 209.52M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $693.45M | $705.58M | $575.82M | $618.07M | $470.27M | -1.7% |
| Cash & short-term investments | $701.71M | $726.29M | $604.23M | $644.08M | $503.78M | -3.4% |
| Accounts receivable | $296.89M | $277.68M | $253.21M | $219.84M | $282.93M | +6.9% |
| Total current assets | $1.16B | $1.15B | $951.58M | $985.32M | $880.12M | +1.3% |
| Property, plant & equipment | $73.52M | $70.94M | $71.27M | $74.36M | $77.10M | +3.6% |
| Goodwill & intangibles | $36.61M | $36.61M | $36.61M | $36.61M | $36.61M | 0.0% |
| Total assets | $1.28B | $1.26B | $1.07B | $1.10B | $1.00B | +1.4% |
| Total current liabilities | $683.41M | $724.76M | $556.87M | $611.09M | $529.53M | -5.7% |
| Long-term debt | $324.06M | $323.62M | $323.18M | $322.74M | $322.30M | +0.1% |
| Total debt | $330.50M | $329.97M | $329.64M | $329.66M | $329.66M | +0.2% |
| Total liabilities | $1.01B | $1.05B | $886.51M | $940.74M | $859.18M | -3.9% |
| Retained earnings | -$961.04M | -$997.60M | -$1.01B | -$998.01M | -$1.00B | +3.7% |
| Shareholder equity | $265.13M | $206.88M | $179.28M | $161.87M | $140.97M | +28.2% |
| Working capital | $477.04M | $420.61M | $394.71M | $374.24M | $350.60M | +13.4% |
| Net tangible assets | $228.52M | $170.28M | $142.67M | $125.26M | $104.36M | +34.2% |
| Shares issued | 207.18M | 206.67M | 204.15M | 199.99M | 197.96M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $36.56M | $11.42M | -$11.01M | $3.73M | $15.65M | +220.3% |
| Depreciation & amortisation | $7.86M | $7.86M | $7.83M | $7.99M | $7.04M | -0.1% |
| Stock-based compensation | $18.17M | $14.02M | $13.12M | $16.23M | $15.55M | +29.6% |
| Change in working capital | -$81.18M | $94.67M | -$61.22M | $115.27M | -$9.23M | -185.8% |
| Operating cash flow | -$17.31M | $128.68M | -$50.38M | $144.56M | $29.13M | -113.5% |
| Capital expenditure | -$10.14M | -$7.36M | -$5.03M | -$5.50M | -$8.00M | -37.8% |
| Investing cash flow | $2.42M | $578.00K | -$7.16M | $2.31M | -$6.66M | +318.3% |
| Financing cash flow | $2.77M | $515.00K | $15.30M | $948.00K | $1.62M | +438.4% |
| Free cash flow | -$27.46M | $121.32M | -$55.40M | $139.06M | $21.13M | -122.6% |
| End cash position | $695.59M | $707.71M | $577.94M | $620.18M | $472.36M | -1.7% |
Options analytics
Put / call volume
36.81
Put-heavy session
Put / call open interest
2.71
Positioning, not flow
Max pain
10.00
+19.5% from spot
ATM implied vol
89.1%
Nearest strike to spot
Skew (10% OTM)
-7.0%
Calls bid over puts
Call volume
286
Contracts, this expiry
Put volume
10.53K
Contracts, this expiry
Heaviest call OI
10.00
7.24K contracts
Heaviest put OI
7.50
12.30K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.20 | 0.25 | +24.4% |
| Mar 2026 | 0.09 | 0.12 | +38.7% |
| Dec 2025 | -0.08 | -0.00 | +98.2% |
| Sep 2025 | -0.01 | 0.10 | +1,081.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 4 | $1.31B | +32.1% |
| Next quarter | 0.05 | 4 | $1.33B | +31.5% |
| Current year | 0.50 | 4 | $5.21B | +32.1% |
| Next year | 0.75 | 4 | $6.49B | +24.5% |
Analyst targets & ownership
Mean target$21.77
High target$28.00
Low target$10.00
Implied upside159.43%
Analyst count13
ConsensusSTRONG BUY
Strong buy / Buy3 / 9
Hold2
Sell / Strong sell0 / 0
Held by insiders2.57%
Held by institutions115.99%
Institutions holding435
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
8.03
+4.51% from price
SMA 20
9.20
-9.06% from price
SMA 50
12.13
-30.99% from price
SMA 100
15.74
-46.68% from price
SMA 200
17.90
-53.24% from price
EMA 12
8.51
-1.44% from price
EMA 26
9.88
-15.11% from price
EMA 50
11.97
-29.89% from price
RSI (14)
33.0
Neutral
MACD (12,26,9)
-1.37
Hist 0.18
ATR (14)
0.56
6.69% of price
Realised vol 30D
89.6%
Annualised
Bollinger upper
13.00
20, 2σ
Bollinger lower
5.41
20, 2σ
50 / 200 cross
Death
12.13 vs 17.90
Trend bias
Below 200
-53.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.48
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
89.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-68.8%
Peak to trough
Max drawdown 5Y
-80.4%
Peak to trough
ATR 14
0.56
6.69% of price
Beta (reported)
1.14
5Y monthly, from filing
Short interest
Shares short
24.62M
Prior 23.53M
Change vs prior
+4.6%
Shorts adding
% of float
12.20%
Elevated
% of shares out
11.87%
Against total outstanding
Days to cover
4.6
Liquid
Float
188.51M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 4, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 3, 26 | Raymond James | DOWNGRADE | Strong Buy | Outperform |
| May 26, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 1, 26 | UBS | MAINTAINED | Neutral | Neutral |
| May 1, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 5, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jan 16, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jan 14, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jan 6, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Dec 17, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Nov 24, 25 | JP Morgan | UPGRADE | Neutral | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-04-30
Proxy Statements
DEFA14A · 2026-04-24
Corporate Changes & Voting Matters
8-K · 2026-03-04
Offering Registrations
S-3ASR · 2026-03-02
Periodic Financial Reports
10-K · 2026-02-27
Headlines
What Is Behind Alignment Healthcare (ALHC) Stock's Latest Move?
Simply Wall St. · 3d ago
Q2 Earnings Highlights: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Health Insurance Providers Stocks
StockStory · 4d ago
Are Options Traders Betting on a Big Move in Alignment Healthcare Stock?
Zacks · 6d ago
Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options
GlobeNewswire · 6d ago
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Avoid
StockStory · 16d ago
Is Alignment Healthcare (ALHC) Still About Right After Its 57% Slide?
Simply Wall St. · 20d ago
Alignment Healthcare Insider Sold Shares Worth $356,200, According to a Recent SEC Filing
MT Newswires · 20d ago
Alignment Healthcare (ALHC) Faces Medicare Advantage Reform, Is It A Bargain?
Simply Wall St. · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.